Alcon's Trading Volume Drops 60.75% Ranking 494th Despite Strong Q1 Revenue

On May 15, 2025, Alcon's trading volume was $194 million, a 60.75% decrease from the previous day, ranking 494th in the day's stock market. Alcon's stock price increased by 0.49%.

Alcon reported its first-quarter 2025 financial results, with revenue reaching $2.47 billion, consistent with the same period last year. The company's net income surged by 41% to $350 million, driven by strong performance across its surgical franchise.

During the earnings call, Alcon highlighted its core operating margin of 20.8% and core diluted earnings of $0.73 per share. The surgical franchise revenue stood at $1.3 billion, contributing significantly to the overall revenue growth.

Despite the strong financial performance, Alcon's core earnings per share (EPS) for the first quarter of 2025 was $0.73, a 6.4% decrease from the same period last year. This discrepancy suggests that while revenue and net income are robust, the company is facing challenges in translating these gains into higher EPS.

Alcon's first-quarter 2025 sales reached $2.5 billion, marking a 3% increase on a constant currency basis compared to the same period in 2024. This growth was driven by strong demand in the surgical franchise and other key segments.

Alcon has updated its 2025 sales growth target to 6%-7%, reflecting its confidence in continued market expansion and product innovation. The company's strategic initiatives and focus on operational efficiency are expected to drive future growth and profitability.